April 15 (Reuters) - Acrux Ltd ACR.AX :
* US FDA HAS ACCEPTED FOR REVIEW ACRUX'S ABBREVIATED NEW DRUG APPLICATION FOR ITS GENERIC VERSION OF DAPSONE GEL
April 15 (Reuters) - Acrux Ltd ACR.AX :
* US FDA HAS ACCEPTED FOR REVIEW ACRUX'S ABBREVIATED NEW DRUG APPLICATION FOR ITS GENERIC VERSION OF DAPSONE GEL